Biomarkers and Surrogate Endpoints in Renal Transplantation: Present Status and Considerations for Clinical Trial Design
Open Access
- 1 April 2004
- journal article
- review article
- Published by Elsevier in American Journal of Transplantation
- Vol. 4 (4) , 451-457
- https://doi.org/10.1111/j.1600-6143.2004.00386.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Poor Predictive Value of Serum Creatinine for Renal Allograft LossAmerican Journal of Transplantation, 2003
- Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsiesTransplantation, 2003
- Heightened Peripheral Blood Lymphocyte CD69 Expression is Neither Sensitive nor Specific as a Noninvasive Diagnostic Test for Renal Allograft RejectionJournal of the American Society of Nephrology, 2003
- High transforming growth factor-?? and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection1Transplantation, 2002
- Noninvasive Diagnosis of Renal-Allograft Rejection by Measurement of Messenger RNA for Perforin and Granzyme B in UrineNew England Journal of Medicine, 2001
- CYTOKINE AND CYTOTOXIC MOLECULE GENE EXPRESSION DETERMINED IN PERIPHERAL BLOOD MONONUCLEAR CELLS IN THE DIAGNOSIS OF ACUTE RENAL REJECTIONTransplantation, 2000
- PROTOCOL RENAL ALLOGRAFT BIOPSIES AND THE DESIGN OF CLINICAL TRIALS AIMED TO PREVENT OR TREAT CHRONIC ALLOGRAFT NEPHROPATHY1Transplantation, 2000
- Correlation of histology to clinical rejection reversal: A Thymoglobulin Multicenter Trial reportKidney International, 1999
- THE CLINICAL USEFULNESS OF THE RENAL ALLOGRAFT BIOPSY IN THE CYCLOSPORINE ERATransplantation, 1999
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999